Push release MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight administration and weight loss For the first time in the united kingdom, obese clients and people who are overweight with weight-associated health problems could now have entry to Mounjaro, now employed for Type 2 diabetes,